MarketPulse

clinical-stage oncology

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Aktis Oncology to Present Radioconjugate Pipeline at BofA Securities Conference

Aktis Oncology presents miniprotein radioconjugate platform at BofA Securities conference, advancing AKY-1189 and AKY-2519 across solid tumor indications.
AKTScancer treatmentclinical-stage oncology
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Boundless Bio Extends Cash Runway to Mid-2028 Amid BBI-940 Clinical Expansion

Boundless Bio reported $107.6M cash, narrowed 2025 net losses to $58.2M, and is advancing lead breast cancer candidate BBI-940 through Phase 2 trials.
BOLDbreast cancercash runway